FDA's VRBPAC Committee Advises on Vaccine Safety and Effectiveness, Not Approval or Policy
The Vaccines and Related Biological Products Advisory Committee (VRBPAC) is a standing panel of external experts that advises the U.S. Food and Drug Administration (FDA) Commissioner on the safety, effectiveness, and appropriate use of vaccines and related biological products. Established in 1979, VRBPAC's role is purely advisory; it reviews and evaluates data but does not make regulatory decisions. The FDA retains full authority to approve or license products. VRBPAC's 15 voting members are experts in fields such as immunology, virology, epidemiology, and vaccine safety. Meetings are generally open to the public, including an open public hearing, and are convened by the FDA as needed, not on a fixed annual schedule. The committee's charter, filed December 31, 2025, terminates on December 31, 2027, unless renewed.